Jones, who joined the 23-strong agency last month, will work for clients such as Roche Pharmaceuticals and Shire Pharmaceuticals. She is managing Resolute’s global PR account for Roche’s colorectal cancer product Avastin and working on the UK account for Shire’s Calcichew osteoporosis brand.
She joins at a crucial time for Calcichew as the National Institute for Clinical Excellence is in the midst of an appraisal of osteoporosis drugs. Resolute is undertaking key opinion-leader development and congress work, plus media relations for the brand.
Jones worked at Lowe Fusion, where she promoted AstraZeneca’s breast-cancer drug Faslodex, for just over two and a half years.